Acumen Hypotension Prediction Index (HPI) Feature Software vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Verily

AI Verdict

Tool A is a predictive software designed for proactive management of hypotension in acute care settings, integrating with advanced monitoring platforms to alert clinicians before an event occurs. Tool B is a wearable device focused on continuous physiological data collection for clinical research and broader remote monitoring, offering features like ECG and heart rate tracking. While both leverage AI for physiological insights, their primary use cases, deployment models, and specific clinical applications are distinct.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your primary goal is real-time, proactive management of hemodynamic instability in high-acuity clinical settings like the OR or ICU. This tool is ideal for clinicians who need early warnings of impending hypotensive events and actionable insights into underlying physiological parameters to guide immediate interventions and improve patient outcomes.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Study Watch if…

Choose Verily Study Watch if you require a non-invasive, continuous physiological monitoring device for long-term data collection in clinical research or remote patient monitoring programs. This wearable is best suited for studies investigating chronic conditions, tracking physiological trends over extended periods, or developing AI-enabled precision health solutions based on comprehensive, real-world data.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software Study Watch
Deployment Unknown The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is integrated directly into the Edwards Lifesciences HemoSphere monitoring platform, providing clinicians with real-time, actionable alerts and insights within their existing workflow. Its design focuses on immediate clinical decision support through smart alerts and trend screens. In contrast, Study Watch is a patient-worn device primarily for data collection in clinical research, with minimal on-device interaction for patients and data viewed by HCPs via a web portal.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI offers direct and immediate clinical value by proactively predicting and reducing the incidence, duration, and severity of intraoperative hypotension, with studies demonstrating significant improvements in patient outcomes. Study Watch, while FDA-cleared for ECG and irregular pulse monitoring, primarily serves as a research tool for continuous physiological data collection to advance understanding and develop future precision health solutions.

Pricing & Value

Tie

Neither tool publicly discloses its pricing information, requiring direct contact with the respective vendors. Without transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their value propositions.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI, from Edwards Lifesciences, is integrated into an established hospital monitoring platform and has clear FDA clearance and HIPAA compliance claims. While Verily Study Watch also has FDA clearance and states HIPAA compliance, an ongoing lawsuit alleging HIPAA violations, though denied by Verily, could introduce perceived risk for enterprise adoption.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is described as a 'first-of-its-kind technology' that uses machine learning to predict hypotensive events up to 15 minutes before they occur, representing a significant innovation in proactive critical care management. While Study Watch's multi-sensor wearable technology for continuous physiological monitoring in clinical research is innovative, Acumen HPI's predictive capability for immediate clinical intervention sets a higher bar for novel impact.

Support & Docs

Tie

Both Edwards Lifesciences and Verily, as large and established companies, offer robust support and documentation. Edwards provides clinical education and product-specific resources for Acumen HPI. Verily offers support resources, data workbench documentation, and regulatory information for Study Watch. Without more specific comparative details on the quality, accessibility, or breadth of these offerings, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software Study Watch
Product Name Acumen Hypotension Prediction Index (HPI) Feature Software Study Watch
Company Edwards Lifesciences Verily Life Sciences
Primary Use Case Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data for analysis in Verily's cloud platform.
Key Monitoring Capabilities Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen, Relationship View screen (preload, afterload, contractility), machine learning analysis of blood pressure waveforms. Continuous physiological monitoring, multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), on-demand single-channel ECG, irregular pulse monitor.
Predictive Analytics for Events Predicts hypotension up to 15 minutes before an event using machine learning algorithms. Not specified for specific event prediction like hypotension; offers cloud-based data processing with algorithms and machine learning.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Edwards Lifesciences' Acumen HPI software is designed for proactive hemodynamic management by detecting and alerting clinicians to the likelihood of a hypotensive event before it occurs. It aids in treating hemodynamic instability. Verily Study Watch is a prescription-only, sensor-based wearable device primarily for non-invasive, continuous physiological monitoring in clinical research.
Acumen HPI provides a Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts, and a Relationship View screen offering insights into preload, afterload, and contractility by analyzing blood pressure waveforms. It is compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. Study Watch offers continuous physiological monitoring through multiple sensors, collecting data such as ECG, heart rate, electrodermal activity, and inertial movements. It also features an irregular pulse monitor and on-demand single-channel ECG.
Yes, Acumen HPI uses machine learning algorithms for predictive analysis of blood pressure waveforms and predicts hypotension up to 15 minutes before an event. It provides a 0-100 score and smart alerts for impending hypotensive events. Study Watch utilizes cloud-based data processing with algorithms and machine learning for analysis of collected physiological data, primarily for clinical research.
Acumen HPI is primarily indicated for Anesthesiology, Critical Care, and Emergency Medicine, focusing on managing hemodynamic instability. Study Watch is relevant for Cardiology, Neurology, and Sleep Medicine, with its primary application being in clinical research and partnerships.
Edwards Lifesciences' Acumen HPI states it has a BAA and is HIPAA compliant. Verily Study Watch states it has a BAA and is HIPAA compliant, but notes an ongoing lawsuit alleging breaches of BAAs and HIPAA violations, which Verily denies.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.